Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
478.00 x 1 492.00 x 3
Post-market by (Cboe BZX)
489.10 +3.21 (+0.66%) 04/17/25 [NASDAQ]
478.00 x 1 492.00 x 3
Post-market 489.10 unch (unch) 16:34 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
485.08
Day High
492.23
Open 492.23
Previous Close 485.89 485.89
Volume 1,205,400 1,205,400
Avg Vol 1,743,965 1,743,965
Stochastic %K 77.34% 77.34%
Weighted Alpha +20.05 +20.05
5-Day Change +13.61 (+2.86%) +13.61 (+2.86%)
52-Week Range 377.85 - 519.88 377.85 - 519.88
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 125,595,992
  • Shares Outstanding, K 256,790
  • Annual Sales, $ 11,020 M
  • Annual Income, $ -535,600 K
  • EBIT $ -233 M
  • EBITDA $ -26 M
  • 60-Month Beta 0.50
  • Price/Sales 11.32
  • Price/Cash Flow N/A
  • Price/Book 7.63

Options Overview Details

View History
  • Implied Volatility 34.04% ( -1.83%)
  • Historical Volatility 23.11%
  • IV Percentile 82%
  • IV Rank 46.39%
  • IV High 52.99% on 12/18/24
  • IV Low 17.64% on 05/16/24
  • Put/Call Vol Ratio 0.90
  • Today's Volume 2,573
  • Volume Avg (30-Day) 1,965
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 41,570
  • Open Int (30-Day) 36,740

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.69
  • Number of Estimates 8
  • High Estimate 3.99
  • Low Estimate 3.47
  • Prior Year 4.29
  • Growth Rate Est. (year over year) -13.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
448.14 +9.14%
on 04/07/25
Period Open: 513.76
516.50 -5.30%
on 03/18/25
-24.66 (-4.80%)
since 03/17/25
3-Month
423.49 +15.49%
on 01/21/25
Period Open: 422.00
519.68 -5.88%
on 03/14/25
+67.10 (+15.90%)
since 01/17/25
52-Week
377.85 +29.44%
on 12/19/24
Period Open: 393.10
519.88 -5.92%
on 11/08/24
+96.00 (+24.42%)
since 04/17/24

Most Recent Stories

More News
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs on...

VRTX : 489.10 (+0.66%)
VEEV : 215.95 (-2.13%)
Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

Yo-yos are fun for kids. But yo-yo stock markets aren't so fun for grown-up investors. And unfortunately, there's been a lot more down "yo" recently than up "yo."

META : 501.48 (-0.17%)
VRTX : 489.10 (+0.66%)
AMZN : 172.61 (-0.99%)
Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

That probably isn't an ancient Chinese curse as some think. However, many investors might wish that the times we live in weren't quite as interesting -- especially when it comes to the Nasdaq Composite...

COMP : 7.29 (-3.95%)
GOOG : 153.36 (-1.38%)
GOOGL : 151.16 (-1.42%)
$NASX : 16,286.45 (-0.13%)
VRTX : 489.10 (+0.66%)
ISRG : 482.74 (+0.29%)
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire, bringing in billions of dollars in revenue annually, and now is even expanding...

CRSP : 37.77 (-0.03%)
VRTX : 489.10 (+0.66%)
We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

Contrary to what you might read on social media, Warren Buffett isn't a fan of tariffs. Berkshire Hathaway even recently took the unusual step of issuing a press release refuting social media claims that...

GOLD : 20.17 (-2.32%)
BRK.A : 778,832.75 (+0.59%)
BRK.B : 518.21 (+0.34%)
VRTX : 489.10 (+0.66%)
BRK.TO : 38.78 (+0.39%)
AMZN : 172.61 (-0.99%)
5 Top Growth Stocks to Buy in the Stock Market Sell-Off

Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary. History tells...

SHOP : 83.65 (-0.37%)
NVO : 58.08 (-7.63%)
LLY : 839.96 (+14.30%)
VRTX : 489.10 (+0.66%)
ISRG : 482.74 (+0.29%)
Is Vertex Pharmaceuticals Stock a Buy?

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX) . Compared to the S&P 500 index, which is down about 16%...

VRTX : 489.10 (+0.66%)
2 Stocks to Buy if You're Worried About a Recession

Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies. Though things might not go that far, it's still worth planning ahead.

HCA : 335.01 (+1.21%)
VRTX : 489.10 (+0.66%)
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

BMRN : 59.17 (+0.60%)
VRTX : 489.10 (+0.66%)
MRNA : 24.72 (-1.89%)
UTHR : 284.73 (-0.16%)
BIIB : 118.61 (+2.88%)
Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm

Stocks are sinking the most since the COVID-19-fueled sell-off in 2020. A global trade war seems imminent. JPMorgan Chase just raised its estimated probability of a recession to 60%. What's the common...

JPM : 231.96 (+1.02%)
EVRG : 68.37 (+1.39%)
KR : 71.22 (+3.20%)
VRTX : 489.10 (+0.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 499.68
2nd Resistance Point 495.95
1st Resistance Point 492.53
Last Price 489.10
1st Support Level 485.38
2nd Support Level 481.65
3rd Support Level 478.23

See More

52-Week High 519.88
Last Price 489.10
Fibonacci 61.8% 465.62
Fibonacci 50% 448.86
Fibonacci 38.2% 432.11
52-Week Low 377.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro